Close to 130 industry and non-industry players, across the globe, claim to have the necessary expertise {Roots Analysis}

The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise. Further, owing to its inherent hazardous nature, radiopharmaceuticals have a complex regulatory market authorization process. Consequently, a number of innovator companies have demonstrated a preference for outsourcing radiopharmaceutical manufacturing to contract service providers.


To order this 320+ page report, which features 45+ figures and 100+ tables, please visit this


The USD 6+ billion (by 2030) financial opportunity associated with nuclear medicine and radiopharmaceuticals manufacturing, has been analyzed across the following segments:

  • Target Disease Indication
  • Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Head and Neck Cancer
  • Lung Cancer
  • Lupus Nephritis
  • Melanoma
  • Multiple Myeloma
  • Primary Sjögren’s Syndrome
  • Others


  • Target Immune Checkpoint
  • B7-H3
  • CD38
  • CD40
  • CD47
  • Others


  • Mechanism of Action
  • Inhibitory
  • Stimulatory


  • Therapeutic Modality
  • Monoclonal Antibody
  • Small Molecule


  • Type of Therapy
  • Monotherapy
  • Combination Therapy


  • Route of Administration
  • Intravenous
  • Subcutaneous
  • Others


  • Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific and the Rest of the World


The Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030” report features the following companies, which we identified to be key players in this domain:

  • Advanced Accelerator Applications
  • Belgian Nuclear Research Center (SCK•CEN)
  • Cardinal Health
  • China Isotope & Radiation Corporation
  • Curium Pharma
  • DuChemBio
  • Eckert & Ziegler
  • Eczacibasi-Monrol
  • GE Healthcare
  • Jubilant DraxImage
  • Lantheus Medical Imaging
  • Nihon Medi-Physics
  • Nordion
  • PETNET Solutions
  • SinoTau Pharmaceuticals


Table of Contents


  1. Preface

    2. Executive Summary

  2. Introduction
  3. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Industry Players): Current Market Landscape
  4. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Non-Industry Players): Current Market Landscape
  5. Nuclear Medicine and Radiopharmaceuticals Manufacturers in North America
  6. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Europe
  7. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Asia-Pacific And Rest of The World
  8. Nuclear Medicine and Radiopharmaceuticals Manufacturers: Company Competitiveness Analysis
  9. Partnerships and Collaborations
  10. Production and Supply Chain of Medical Isotope Molybdenum-99 (Technetium-99m)
  11. Market Forecast and Opportunity Analysis
  12. Concluding Remarks


  1. Executive Insights


  1. Appendix 1: Tabulated Data


  1. Appendix 2: List of Companies and Organizations


To purchase a copy, please visit


Contact Details

Gaurav Chaudhary

+1 (415) 800 3415